Company intelligence / Profile preview

Molecular Oncology

Gaithersburg, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Molecular Oncology was a specialized biotechnology company focused on the development and commercialization of molecular diagnostic tests for cancer. The company provided advanced testing services to help oncologists identify genetic mutations and biomarkers, enabling more personalized treatment strategies for patients with solid tumors and blood cancers. Its portfolio included assays for gene expression profiling and mutation detection. The company was eventually acquired by Laboratory Corporation of America (LabCorp), where its technologies and expertise were integrated into LabCorp's broader oncology and genomic testing divisions.

Therapeutic areas: Oncology
Modalities: Diagnostic testMolecular diagnostics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Molecular Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Molecular Oncology.

Explore the full profile